THNR

ETFNYSEARCA 已收盘

Amplify Weight Loss Drug & Treatment ETF

24.26 USD
▼-0.44-1.78%
盘后 24.26 0.00%
2026-11-20
市值
—
规模 AUM
$5.01M
EPS
—
股息率
1.70%
52 周区间
23.40 – 27.94
成交量
0.00
Beta
0.40
目标价
—
52W 低 23.4052W 高 27.94
价格走势

公司简介

The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that mostly invests in health care stocks. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.